CORONAVIRUS CATASTROPHE: THE VALUE OF INTELLECTUAL PROPERTY DURING AN ECONOMIC DOWNTURN By: Katie Rubino As the number of cases of the novel coronavirus around the world […]
COVID-19 EPIDEMIC: CAN THE COVID-19 VIRUS BE PATENTED? By: Katie Rubino Just last week, the outbreak of a novel coronavirus that originated in China, has been […]
THE GLOBAL CORONAVIRUS PANDEMIC: THE RACE FOR PATENT RIGHTS By: Katie Rubino All over the news, there are stories about the new coronavirus (Covid-19). Coronavirus […]
Innovator Spotlight – Cyrus Schenck By: Emily Gaukstern Cyrus Schenck is the local founder of Renoun, a company focused on producing revolutionary skis composed of […]
FEDERAL CIRCUIT TO EXAMINE THE STANDING OF INVALIDITY DETERMINATIONS IN PRIOR INTER PARTES REVIEW PROCEEDINGS By: Emily Gaukstern On October 31st, 2019 the […]
PATENT TRIAL & APPEAL BOARD HIGHLIGHTS TRAP FOR THE UNWARY By: Milton Oliver A significant portion of patent litigation has shifted, in recent years, from […]
POST GRANT PROCEEDINGS SERIES Is IPR the best decision for me? By: Emily Gaukstern The America Invents Act (AIA), put into effect September 16, 2012, […]
ALLERGAN BATTLES TO KEEP BOTOX-MANUFACTURING PROCESS A TRADE SECRET By: Emily Gaukstern Allergan Plc (“Allergan”) has filed a motion challenging a trade judge’s […]
CAFC TO HEAR MEDTECH PATENT DISPUTE BETWEEN 23ANDME, INC. V. ANCESTRY.COM DNA, LLC By: Katie Rubino On October 2nd, 2019 oral arguments commenced at […]